A Study to Learn How Gadoquatrane Moves Into, Through, and Out of the Body and How Safe it is in Children (From Birth to <18 Years), Who Will Undergo a Contrast Enhanced MRI (Quanti Pediatric)

Clinical trial NCT05915026 · COMPLETED

Trial details

NCT number: NCT05915026
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Contrast Enhancement in Magnetic Resonance Imaging Children

Start date: 2023-08-16
Primary completion: 2024-09-18
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.